Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 0.80 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.70 |
| ▸ | HTR1A | P08908 | 1/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.61 |
| ▸ | HTR2B | P41595 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5302319 | 1.00 | HTR2A (0.80) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| SCHEMBL2556573 | 1.00 | HTR2A (0.80) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| SCHEMBL2556577 | 1.00 | HTR2A (0.80) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| SCHEMBL5302329 | 1.00 | HTR2A (0.80) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| Hydrochloric Acid SCHEMBL2761491 | 0.98 | HTR2A (0.77) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| Hydrochloric Acid SCHEMBL2761490 | 0.98 | HTR2A (0.77) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| SCHEMBL5304945 | 0.98 | HTR2A (0.77) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| SCHEMBL5304943 | 0.98 | HTR2A (0.77) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| SCHEMBL5303673 | 0.97 | HTR2A (0.74) | HTR2ATAAR1HTR1AHTR2CHTR2B | |
| SCHEMBL5305069 | 0.97 | HTR2A (0.74) | HTR2ATAAR1HTR1AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4452986-A1 | SEROTONIN RECEPTOR AGONISTS AND METHODS OF MAKING AND USING THE SAME | Kuleon LLC (US) | 2024-10-30 | — | — | EP | disclosed |
| CN-118055766-A | Magic and non-magic serotonin receptor agonist and its preparing process and usage | 库莱恩有限责任公司 | 2024-05-17 | — | — | CN | disclosed |
| WO-2023225043-A1 | TRICYCLIC AND TETRACYCLIC SEROTONIN RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME | KULEON LLC (US) | 2023-11-23 | — | — | WO | disclosed |
| EP-4251181-A1 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL CONDITIONS | Wesana Health Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-4251139-A2 | COMPOSITIONS AND METHODS FOR TREATING MIGRAINE | Wesana Health Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023122135-A1 | SEROTONIN RECEPTOR AGONISTS AND METHODS OF MAKING AND USING THE SAME | KULEON LLC (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023023298-A1 | HALLUCINOGENIC AND NON-HALLUCINOGENIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | PSILOSTERICS, LLC (US) | 2023-02-23 | — | — | WO | disclosed |
| WO-2022115798-A2 | COMPOSITIONS AND METHODS FOR TREATING MIGRAINE | WESANA HEALTH INC. (US) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022115796-A1 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL CONDITIONS | WESANA HEALTH INC. (US) | 2022-06-02 | — | — | WO | disclosed |